betaxolol has been researched along with apraclonidine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cepurna, WO; Johnson, E; Lauer, AK; Morrison, JC; Nylander, KB | 1 |
| Di Govanni, A; Fusco, R; Lamberti, G; Pignalosa, B; Pignalosa, G; Sebastiani, A | 1 |
| Kaya, M; Mete, U; Ozdemir, N; Polat, S; Soylu, M; Unlügenç, Z | 1 |
| Cantor, LB; Hoop, J; Katz, LJ; Lin, JC; Samuel, F; Spaeth, GL | 1 |
2 trial(s) available for betaxolol and apraclonidine
| Article | Year |
|---|---|
Short-term clinical trial evaluating the efficacy of the combination of apraclonidine 0.5% solution and betaxolol 0.25% suspension.
Topics: Adolescent; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Betaxolol; Chronic Disease; Circadian Rhythm; Clonidine; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Single-Blind Method; Suspensions; Treatment Outcome | 1997 |
The effect of topical glaucoma medications evaluated by perimetry.
Topics: Administration, Topical; Antihypertensive Agents; Betaxolol; Clonidine; Epinephrine; Glaucoma; Humans; Intraocular Pressure; Levobunolol; Prospective Studies; Sulfonamides; Thiophenes; Visual Field Tests | 2003 |
3 other study(ies) available for betaxolol and apraclonidine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Glaucoma drops control intraocular pressure and protect optic nerves in a rat model of glaucoma.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Clonidine; Disease Models, Animal; Glaucoma; Intraocular Pressure; Male; Nerve Fibers; Ocular Hypertension; Ophthalmic Solutions; Optic Nerve; Optic Nerve Diseases; Rats; Rats, Inbred BN; Tonometry, Ocular | 1998 |
Ultrastructural effects of topical beta-adrenergic antagonists and an alpha-adrenergic agonist on the rabbit cornea.
Topics: Administration, Topical; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Clonidine; Cornea; Cytoplasm; Endoplasmic Reticulum; Levobunolol; Microvilli; Ophthalmic Solutions; Rabbits; Timolol | 1999 |